Advances in Cystic Fibrosis, An Issue of Clinics in Chest Medicine

Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations<br>Genetics of Cystic Fibrosis: Clinical Implications<br>Update on Innate and Adaptive Immunity in Cystic Fibrosis<br>Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis<br>Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators<br>The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation<br>Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis<br>Update on Clinical Outcomes of Highly Effective Modulator Therapy<br>Nontuberculous Mycobacterial Infections in Cystic Fibrosis<br>Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient<br>Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era<br>Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis<br>Transitions of Care in Cystic Fibrosis<br>Endocrine Complications of Cystic Fibrosis<br>Management of Mental Health in Cystic Fibrosis<br>Family Planning and Reproductive Health in Cystic Fibrosis<br>Update on Lung Transplantation for Cystic Fibrosis